{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:17:29Z","timestamp":1792052249859,"version":"4.4.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00296-019-04371-z","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T18:02:21Z","timestamp":1562954541000},"page":"1507-1517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Comorbidity burden in systemic sclerosis: beyond disease-specific complications"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5755-1538","authenticated-orcid":false,"given":"Eleni","family":"Pagkopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3180-7280","authenticated-orcid":false,"given":"Alexandra","family":"Arvanitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8027-3655","authenticated-orcid":false,"given":"Dimitrios","family":"Daoussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7289-1293","authenticated-orcid":false,"given":"Alexandros","family":"Garyfallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0828-6176","authenticated-orcid":false,"given":"George","family":"Kitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-1642","authenticated-orcid":false,"given":"Theodoros","family":"Dimitroulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"4371_CR1","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","volume":"51","author":"M Elhai","year":"2012","unstructured":"Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40\u00a0years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 51:1017\u20131026","journal-title":"Rheumatology (Oxford)"},{"key":"4371_CR2","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s00296-017-3826-y","volume":"38","author":"DR Poudel","year":"2018","unstructured":"Poudel DR, Jayakumar D, Danve A, Sehra ST, Derk CT (2018) Determinants of mortality in systemic sclerosis: a focused review. Rheumatol Int 38:1847\u20131858","journal-title":"Rheumatol Int"},{"key":"4371_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","volume":"44","author":"M Rubio-Rivas","year":"2014","unstructured":"Rubio-Rivas M, Royo C, Simeon CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44:208\u2013219","journal-title":"Semin Arthritis Rheum"},{"key":"4371_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.31138\/mjr.27.3.102","volume":"27","author":"P Konstantopoulou","year":"2016","unstructured":"Konstantopoulou P, Gialafos E, Moyssakis I, Tountas C, Konsta M, Vaiopoulos G, Sfikakis P (2016) Evolution and management of late onset cardiac involvement in a contemporary systemic sclerosis cohort. Mediterr J Rheumatol 27:102\u2013107","journal-title":"Mediterr J Rheumatol"},{"key":"4371_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10067-017-3951-8","volume":"38","author":"RPV de Rezende","year":"2019","unstructured":"de Rezende RPV, Gismondi RA, Maleh HC, de Miranda Coelho EM, Vieira CS, Rosa MLG, Mocarzel LO (2019) Distinct mortality profile in systemic sclerosis: a death certificate study in Rio de Janeiro, Brazil (2006\u20132015) using a multiple causes of death analysis. Clin Rheumatol 38:189\u2013194","journal-title":"Clin Rheumatol"},{"key":"4371_CR6","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.2174\/0929867322666150209161224","volume":"22","author":"T Dimitroulas","year":"2015","unstructured":"Dimitroulas T, Daoussis D, Garyfallos A, Sfikakis PP, Kitas GD (2015) Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis. Curr Med Chem 22:1943\u20131955","journal-title":"Curr Med Chem"},{"key":"4371_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.31138\/mjr.30.1.33","volume":"30","author":"D Daoussis","year":"2019","unstructured":"Daoussis D, Liossis SN (2019) Treatment of systemic sclerosis associated fibrotic manifestations: current options and future directions. Mediterr J Rheumatol 30:33\u201337","journal-title":"Mediterr J Rheumatol"},{"key":"4371_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13075-018-1771-0","volume":"20","author":"S Panopoulos","year":"2018","unstructured":"Panopoulos S, Tektonidou M, Drosos AA, Liossis SN, Dimitroulas T, Garyfallos A, Sakkas L, Boumpas D, Voulgari PV, Daoussis D, Thomas K, Georgiopoulos G, Vosvotekas G, Vassilopoulos D, Sfikakis PP (2018) Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study. Arthritis Res Ther 20:267","journal-title":"Arthritis Res Ther"},{"key":"4371_CR9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417","journal-title":"Rheumatol Int"},{"key":"4371_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325\u2013331","journal-title":"Ann Rheum Dis"},{"key":"4371_CR11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fmed.2017.00262","volume":"4","author":"V Teixeira","year":"2017","unstructured":"Teixeira V, Tam LS (2017) Novel insights in systemic lupus erythematosus and atherosclerosis. Front Med (Lausanne) 4:262","journal-title":"Front Med (Lausanne)"},{"key":"4371_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/MAJ.0000000000000282","volume":"348","author":"M Sebastiani","year":"2014","unstructured":"Sebastiani M, Manfredi A, Cassone G, Giuggioli D, Ghizzoni C, Ferri C (2014) Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models. Am J Med Sci 348:331\u2013336","journal-title":"Am J Med Sci"},{"key":"4371_CR13","first-page":"469","volume":"22","author":"P Youssef","year":"1995","unstructured":"Youssef P, Brama T, Englert H, Bertouch J (1995) Limited scleroderma is associated with increased prevalence of macrovascular disease. J Rheumatol 22:469\u2013472","journal-title":"J Rheumatol"},{"key":"4371_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.semarthrit.2008.06.002","volume":"39","author":"FF Al-Dhaher","year":"2010","unstructured":"Al-Dhaher FF, Pope JE, Ouimet JM (2010) Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 39:269\u2013277","journal-title":"Semin Arthritis Rheum"},{"key":"4371_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/acr.22152","volume":"66","author":"AJ Dave","year":"2014","unstructured":"Dave AJ, Fiorentino D, Lingala B, Krishnan E, Chung L (2014) Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 66:323\u2013327","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4371_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/ard.57.11.682","volume":"57","author":"R Hesselstrand","year":"1998","unstructured":"Hesselstrand R, Scheja A, Akesson A (1998) Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57:682\u2013686","journal-title":"Ann Rheum Dis"},{"key":"4371_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/rheumatology\/37.7.750","volume":"37","author":"S Jacobsen","year":"1998","unstructured":"Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750\u2013755","journal-title":"Br J Rheumatol"},{"key":"4371_CR18","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Muller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumanovics G, Coleiro B, Feierl E, Szucs G, Von Muhlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kotter I, Simsek I, de la Pena Lefebvre PG, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809\u20131815","journal-title":"Ann Rheum Dis"},{"key":"4371_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2340\/00015555-2842","volume":"98","author":"JH Hesselvig","year":"2018","unstructured":"Hesselvig JH, Kofoed K, Wu JJ, Dreyer L, Gislason G, Ahlehoff O (2018) Localized scleroderma, systemic sclerosis and cardiovascular risk: a danish nationwide cohort study. Acta Derm Venereol 98:361\u2013365","journal-title":"Acta Derm Venereol"},{"key":"4371_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.amjmed.2015.10.037","volume":"129","author":"JA Avina-Zubieta","year":"2016","unstructured":"Avina-Zubieta JA, Man A, Yurkovich M, Huang K, Sayre EC, Choi HK (2016) Early cardiovascular disease after the diagnosis of systemic sclerosis. Am J Med 129:324\u2013331","journal-title":"Am J Med"},{"key":"4371_CR21","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1136\/annrheumdis-2012-202007","volume":"72","author":"A Man","year":"2013","unstructured":"Man A, Zhu Y, Zhang Y, Dubreuil M, Rho YH, Peloquin C, Simms RW, Choi HK (2013) The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis 72:1188\u20131193","journal-title":"Ann Rheum Dis"},{"key":"4371_CR22","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1136\/annrheumdis-2011-201176","volume":"71","author":"GS Ngian","year":"2012","unstructured":"Ngian GS, Sahhar J, Proudman SM, Stevens W, Wicks IP, Van Doornum S (2012) Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis. Ann Rheum Dis 71:1980\u20131983","journal-title":"Ann Rheum Dis"},{"key":"4371_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.amjmed.2013.06.025","volume":"126","author":"SY Chu","year":"2013","unstructured":"Chu SY, Chen YJ, Liu CJ, Tseng WC, Lin MW, Hwang CY, Chen CC, Lee DD, Chen TJ, Chang YT, Wang WJ, Liu HN (2013) Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study. Am J Med 126:982\u2013988","journal-title":"Am J Med"},{"key":"4371_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/art.23540","volume":"59","author":"V Khurma","year":"2008","unstructured":"Khurma V, Meyer C, Park GS, McMahon M, Lin J, Singh RR, Khanna D (2008) A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum 59:591\u2013597","journal-title":"Arthritis Rheum"},{"key":"4371_CR25","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/art.30283","volume":"63","author":"MY Mok","year":"2011","unstructured":"Mok MY, Lau CS, Chiu SS, Tso AW, Lo Y, Law LS, Mak KF, Wong WS, Khong PL, Lam KS (2011) Systemic sclerosis is an independent risk factor for increased coronary artery calcium deposition. Arthritis Rheum 63:1387\u20131395","journal-title":"Arthritis Rheum"},{"key":"4371_CR26","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/ar4267","volume":"15","author":"A Nordin","year":"2013","unstructured":"Nordin A, Jensen-Urstad K, Bjornadal L, Pettersson S, Larsson A, Svenungsson E (2013) Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study. Arthritis Res Ther 15:R87","journal-title":"Arthritis Res Ther"},{"key":"4371_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/1756-185X.12566","volume":"18","author":"H Ali","year":"2015","unstructured":"Ali H, Ng KR, Low AH (2015) A qualitative systematic review of the prevalence of coronary artery disease in systemic sclerosis. Int J Rheum Dis 18:276\u2013286","journal-title":"Int J Rheum Dis"},{"key":"4371_CR28","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s10067-014-2681-4","volume":"33","author":"P Ungprasert","year":"2014","unstructured":"Ungprasert P, Charoenpong P, Ratanasrimetha P, Thongprayoon C, Cheungpasitporn W, Suksaranjit P (2014) Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis. Clin Rheumatol 33:1099\u20131104","journal-title":"Clin Rheumatol"},{"key":"4371_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3109\/14397595.2015.1056931","volume":"26","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Sanguankeo A, Upala S (2016) Risk of ischemic stroke in patients with systemic sclerosis: a systematic review and meta-analysis. Mod Rheumatol 26:128\u2013131","journal-title":"Mod Rheumatol"},{"key":"4371_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/BOR.0000000000000115","volume":"26","author":"A Soriano","year":"2014","unstructured":"Soriano A, Afeltra A, Shoenfeld Y (2014) Is atherosclerosis accelerated in systemic sclerosis? Novel insights. Curr Opin Rheumatol 26:653\u2013657","journal-title":"Curr Opin Rheumatol"},{"key":"4371_CR31","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685\u20131695","journal-title":"N Engl J Med"},{"issue":"5\u20136","key":"4371_CR32","first-page":"8","volume":"30","author":"J Xu","year":"2010","unstructured":"Xu J, Lupu F, Esmon CT (2010) Inflammation, innate immunity and blood coagulation. Hamostaseologie 30(5\u20136):8\u20139","journal-title":"Hamostaseologie"},{"key":"4371_CR33","first-page":"483","volume":"53","author":"BH Bulkley","year":"1976","unstructured":"Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM (1976) Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 53:483\u2013490","journal-title":"A cause of cardiac dysfunction. Circulation"},{"key":"4371_CR34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","volume":"46","author":"WA D\u2019Angelo","year":"1969","unstructured":"D\u2019Angelo WA, Fries JF, Masi AT, Shulman LE (1969) Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46:428\u2013440","journal-title":"Am J Med"},{"key":"4371_CR35","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/rheumatology\/kel120","volume":"45","author":"MR Akram","year":"2006","unstructured":"Akram MR, Handler CE, Williams M, Carulli MT, Andron M, Black CM, Denton CP, Coghlan JG (2006) Angiographically proven coronary artery disease in scleroderma. Rheumatology (Oxford) 45:1395\u20131398","journal-title":"Rheumatology (Oxford)"},{"key":"4371_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/ard.2008.096255","volume":"69","author":"A Komocsi","year":"2010","unstructured":"Komocsi A, Pinter T, Faludi R, Magyari B, Bozo J, Kumanovics G, Minier T, Radics J, Czirjak L (2010) Overlap of coronary disease and pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 69:202\u2013205","journal-title":"Ann Rheum Dis"},{"key":"4371_CR37","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10067-005-0073-5","volume":"25","author":"G el Tarek","year":"2006","unstructured":"el Tarek G, Yasser AE, Gheita T (2006) Coronary angiographic findings in asymptomatic systemic sclerosis. Clin Rheumatol 25:487\u2013490","journal-title":"Clin Rheumatol"},{"key":"4371_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00296-016-3530-3","volume":"37","author":"A Psarras","year":"2017","unstructured":"Psarras A, Soulaidopoulos S, Garyfallos A, Kitas G, Dimitroulas T (2017) A critical view on cardiovascular risk in systemic sclerosis. Rheumatol Int 37:85\u201395","journal-title":"Rheumatol Int"},{"key":"4371_CR39","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/acr.22852","volume":"68","author":"G Ozen","year":"2016","unstructured":"Ozen G, Inanc N, Unal AU, Korkmaz F, Sunbul M, Ozmen M, Akar S, Deniz R, Donmez S, Pamuk ON, Atagunduz P, Tigen K, Direskeneli H (2016) Subclinical atherosclerosis in systemic sclerosis: not less frequent than rheumatoid arthritis and not detected with cardiovascular risk indices. Arthritis Care Res (Hoboken) 68:1538\u20131546","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4371_CR40","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/art.30380","volume":"63","author":"K Au","year":"2011","unstructured":"Au K, Singh MK, Bodukam V, Bae S, Maranian P, Ogawa R, Spiegel B, McMahon M, Hahn B, Khanna D (2011) Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum 63:2078\u20132090","journal-title":"Arthritis Rheum"},{"key":"4371_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/BOR.0000000000000112","volume":"26","author":"N Altorok","year":"2014","unstructured":"Altorok N, Wang Y, Kahaleh B (2014) Endothelial dysfunction in systemic sclerosis. Curr Opin Rheumatol 26:615\u2013620","journal-title":"Curr Opin Rheumatol"},{"key":"4371_CR42","first-page":"827","volume":"33","author":"PJ Kotyla","year":"2006","unstructured":"Kotyla PJ, Lewicki M, Kucharz EJ (2006) Hypothyroidism contributes to increased triglyceride levels among patients with systemic sclerosis. J Rheumatol 33:827 (author reply 627)","journal-title":"J Rheumatol"},{"key":"4371_CR43","first-page":"629","volume":"32","author":"M Kodera","year":"2005","unstructured":"Kodera M, Hayakawa I, Komura K, Yanaba K, Hasegawa M, Takehara K, Sato S (2005) Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations. J Rheumatol 32:629\u2013636","journal-title":"J Rheumatol"},{"key":"4371_CR44","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/rheumatology\/kel426","volume":"46","author":"G Szucs","year":"2007","unstructured":"Szucs G, Timar O, Szekanecz Z, Der H, Kerekes G, Szamosi S, Shoenfeld Y, Szegedi G, Soltesz P (2007) Endothelial dysfunction precedes atherosclerosis in systemic sclerosis\u2013relevance for prevention of vascular complications. Rheumatology (Oxford) 46:759\u2013762","journal-title":"Rheumatology (Oxford)"},{"key":"4371_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00296-004-0580-8","volume":"25","author":"EF Borba","year":"2005","unstructured":"Borba EF, Borges CT, Bonfa E (2005) Lipoprotein profile in limited systemic sclerosis. Rheumatol Int 25:379\u2013383","journal-title":"Rheumatol Int"},{"key":"4371_CR46","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.idc.2006.09.007","volume":"20","author":"GS Alarcon","year":"2006","unstructured":"Alarcon GS (2006) Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis\/dermatomyositis. Infect Dis Clin N Am 20:849\u2013875","journal-title":"Infect Dis Clin N Am"},{"issue":"733\u2013746","key":"4371_CR47","first-page":"ix","volume":"19","author":"UB Prakash","year":"1998","unstructured":"Prakash UB (1998) Respiratory complications in mixed connective tissue disease. Clin Chest Med 19(733\u2013746):ix","journal-title":"Clin Chest Med"},{"issue":"97\u2013113","key":"4371_CR48","first-page":"ix","volume":"83","author":"E Domenech","year":"1999","unstructured":"Domenech E, Kelly J (1999) Swallowing disorders. Med Clin N Am 83(97\u2013113):ix","journal-title":"Med Clin N Am"},{"key":"4371_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0025-7125(05)70508-3","volume":"81","author":"H Mitchell","year":"1997","unstructured":"Mitchell H, Bolster MB, LeRoy EC (1997) Scleroderma and related conditions. Med Clin N Am 81:129\u2013149","journal-title":"Med Clin N Am"},{"key":"4371_CR50","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/ard.40.6.612","volume":"40","author":"CN Rajapakse","year":"1981","unstructured":"Rajapakse CN, Bancewicz J, Jones CJ, Jayson MI (1981) Pharyngo-oesophageal dysphagia in systemic sclerosis. Ann Rheum Dis 40:612\u2013614","journal-title":"Ann Rheum Dis"},{"key":"4371_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","volume":"81","author":"C Ferri","year":"2002","unstructured":"Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Bullo A, Cazzato M, Tirri E, Storino F, Giuggioli D, Cuomo G, Rosada M, Bombardieri S, Todesco S, Tirri G (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81:139\u2013153","journal-title":"Medicine (Baltimore)"},{"key":"4371_CR52","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00005792-200203000-00005","volume":"81","author":"L Scussel-Lonzetti","year":"2002","unstructured":"Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, Raymond Y, Senecal JL (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81:154\u2013167","journal-title":"Medicine (Baltimore)"},{"key":"4371_CR53","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/1529-0131(199802)41:2<373::AID-ART23>3.0.CO;2-S","volume":"41","author":"J Pando","year":"1998","unstructured":"Pando J, Nashel DJ (1998) Clinical images: progressive calcifications and draining lesions following staphylococcal infection in a patient with limited scleroderma. Arthritis Rheum 41:373","journal-title":"Arthritis Rheum"},{"key":"4371_CR54","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00296-015-3241-1","volume":"35","author":"Garcia de la Pena","year":"2015","unstructured":"de la Pena Garcia, Lefebvre P, Nishishinya MB, Pereda CA, Loza E, Sifuentes Giraldo WA, Roman Ivorra JA, Carreira P, Rua-Figueroa I, Pego-Reigosa JM, Munoz-Fernandez S (2015) Efficacy of Raynaud\u2019s phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review. Rheumatol Int 35:1447\u20131459","journal-title":"Rheumatol Int"},{"key":"4371_CR55","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1001\/archinte.1988.00380060217039","volume":"148","author":"RL Minor Jr","year":"1988","unstructured":"Minor RL Jr, Baum S, Schulze-Delrieu KS (1988) Pyomyositis in a patient with progressive systemic sclerosis. Case report and review of the literature. Arch Intern Med 148:1453\u20131455","journal-title":"Arch Intern Med"},{"key":"4371_CR56","first-page":"705","volume":"16","author":"G Pialoux","year":"1992","unstructured":"Pialoux G, Mouly F, Cadranel JF, Flejou JF, Marcellin P, Belghiti J (1992) Infection of ascitic fluid by perforation of a sclerodermic colon. Gastroenterol Clin Biol 16:705\u2013707","journal-title":"Gastroenterol Clin Biol"},{"key":"4371_CR57","first-page":"35","volume":"8","author":"BH Walz","year":"1995","unstructured":"Walz BH, Crosby LA (1995) Mycobacterium avium-intracellulare infection of the knee joint. Case report. Am J Knee Surg 8:35\u201337","journal-title":"Am J Knee Surg"},{"key":"4371_CR58","first-page":"2523","volume":"31","author":"JC Gerster","year":"2004","unstructured":"Gerster JC, Duvoisin B, Dudler J, Berner IC (2004) Tenosynovitis of the Hands Caused by Mycobacterium kansasii in a patient with scleroderma. J Rheumatol 31:2523\u20132525","journal-title":"J Rheumatol"},{"key":"4371_CR59","first-page":"650","volume":"25","author":"N Yazawa","year":"1998","unstructured":"Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, Tamaki T, Tamaki K (1998) High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol 25:650\u2013653","journal-title":"J Rheumatol"},{"key":"4371_CR60","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M","volume":"42","author":"MM Ward","year":"1999","unstructured":"Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42:780\u2013789","journal-title":"Arthritis Rheum"},{"key":"4371_CR61","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3899\/jrheum.131125","volume":"41","author":"SM Ou","year":"2014","unstructured":"Ou SM, Fan WC, Chou KT, Yeh CM, Su VY, Hung MH, Chang YS, Lee YJ, Chen YT, Chao PW, Yang WC, Chen TJ, Wang WS, Tsao HM, Chen LF, Lee FY, Liu CJ (2014) Systemic sclerosis and the risk of tuberculosis. J Rheumatol 41:1662\u20131669","journal-title":"J Rheumatol"},{"key":"4371_CR62","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/ard.60.6.577","volume":"60","author":"M Binks","year":"2001","unstructured":"Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, Finke J, Peter HH, van Laar J, Breedveld FC, Fibbe WE, Farge D, Gluckman E, Locatelli F, Martini A, van den Hoogen F, van de Putte L, Schattenberg AV, Arnold R, Bacon PA, Emery P, Espigado I, Hertenstein B, Hiepe F, Kashyap A, Kotter I, Marmont A, Martinez A, Pascual MJ, Gratwohl A, Prentice HG, Black C, Tyndall A (2001) Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis 60:577\u2013584","journal-title":"Ann Rheum Dis"},{"key":"4371_CR63","first-page":"838","volume":"20","author":"RM Silver","year":"1993","unstructured":"Silver RM, Warrick JH, Kinsella MB, Staudt LS, Baumann MH, Strange C (1993) Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol 20:838\u2013844","journal-title":"J Rheumatol"},{"key":"4371_CR64","doi-asserted-by":"publisher","first-page":"871","DOI":"10.7326\/0003-4819-132-11-200006060-00004","volume":"132","author":"JR Seibold","year":"2000","unstructured":"Seibold JR, Korn JH, Simms R, Clements PJ, Moreland LW, Mayes MD, Furst DE, Rothfield N, Steen V, Weisman M, Collier D, Wigley FM, Merkel PA, Csuka ME, Hsu V, Rocco S, Erikson M, Hannigan J, Harkonen WS, Sanders ME (2000) Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 132:871\u2013879","journal-title":"Ann Intern Med"},{"key":"4371_CR65","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.berh.2016.10.009","volume":"30","author":"K Thomas","year":"2016","unstructured":"Thomas K, Vassilopoulos D (2016) Immunization in patients with inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 30:946\u2013963","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4371_CR66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.31138\/mjr.28.1.41","volume":"28","author":"D Papadopoulou","year":"2017","unstructured":"Papadopoulou D, Trontzas P (2017) A survey to evaluate the implementation of vaccine recommendations among rheumatologists practicing in Greece. Mediterr J Rheumatol 28:51\u201357","journal-title":"Mediterr J Rheumatol"},{"key":"4371_CR67","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/ard.2010.137216","volume":"70","author":"S van Assen","year":"2011","unstructured":"van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, Emery P, Geborek P, Ioannidis JP, Jayne DR, Kallenberg CG, Muller-Ladner U, Shoenfeld Y, Stojanovich L, Valesini G, Wulffraat NM, Bijl M (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70:414\u2013422","journal-title":"Ann Rheum Dis"},{"key":"4371_CR68","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1749-6632.2009.04800.x","volume":"1173","author":"O Launay","year":"2009","unstructured":"Launay O, Guillevin L, Mouthon L (2009) Immunizations in adult patients with systemic sclerosis. Ann N Y Acad Sci 1173:610\u2013618","journal-title":"Ann N Y Acad Sci"},{"key":"4371_CR69","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1093\/rheumatology\/kex330","volume":"57","author":"PD Sampaio-Barros","year":"2018","unstructured":"Sampaio-Barros PD, Andrade DCO, Seguro LCP, Pasoto SG, Viana VST, Ribeiro ACM, Aikawa NE, Timenetsky M, Precioso AR, Silva CA, Bonfa E (2018) Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis. Rheumatology (Oxford) 57:1721\u20131725","journal-title":"Rheumatology (Oxford)"},{"key":"4371_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/art.40893","author":"AA Shah","year":"2019","unstructured":"Shah AA, Laiho M, Rosen A, Casciola-Rosen L (2019) Scleroderma patients with antibodies against the large subunits of both RNA polymerases-I and -III are protected against cancer. Arthritis Rheumatol. \n                    https:\/\/doi.org\/10.1002\/art.40893\n                    \n                   (epub ahead of print)","journal-title":"Arthritis Rheumatol"},{"key":"4371_CR71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/SMJ.0b013e31815838ce","volume":"101","author":"M Wooten","year":"2008","unstructured":"Wooten M (2008) Systemic sclerosis and malignancy: a review of the literature. South Med J 101:59\u201362","journal-title":"South Med J"},{"key":"4371_CR72","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.autrev.2006.03.007","volume":"6","author":"E Szekanecz","year":"2006","unstructured":"Szekanecz E, Andras C, Sandor Z, Antal-Szalmas P, Szanto J, Tamasi L, Kiss E, Szekanecz Z (2006) Malignancies and soluble tumor antigens in rheumatic diseases. Autoimmun Rev 6:42\u201347","journal-title":"Autoimmun Rev"},{"key":"4371_CR73","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10067-008-0925-x","volume":"27","author":"E Szekanecz","year":"2008","unstructured":"Szekanecz E, Szamosi S, Gergely L, Keszthelyi P, Szekanecz Z, Szucs G (2008) Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis. Clin Rheumatol 27:1163\u20131166","journal-title":"Clin Rheumatol"},{"key":"4371_CR74","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/art.37969","volume":"65","author":"A Onishi","year":"2013","unstructured":"Onishi A, Sugiyama D, Kumagai S, Morinobu A (2013) Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 65:1913\u20131921","journal-title":"Arthritis Rheum"},{"key":"4371_CR75","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","volume":"343","author":"CG Joseph","year":"2014","unstructured":"Joseph CG, Darrah E, Shah AA, Skora AD, Casciola-Rosen LA, Wigley FM, Boin F, Fava A, Thoburn C, Kinde I, Jiao Y, Papadopoulos N, Kinzler KW, Vogelstein B, Rosen A (2014) Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 343:152\u2013157","journal-title":"Science"},{"key":"4371_CR76","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.3389\/fimmu.2018.03112","volume":"9","author":"ATJ Maria","year":"2018","unstructured":"Maria ATJ, Partouche L, Goulabchand R, Riviere S, Rozier P, Bourgier C, Le Quellec A, Morel J, Noel D, Guilpain P (2018) Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors. Front Immunol 9:3112","journal-title":"Front Immunol"},{"key":"4371_CR77","doi-asserted-by":"publisher","first-page":"e1588084","DOI":"10.1080\/2162402X.2019.1588084","volume":"8","author":"A Watad","year":"2019","unstructured":"Watad A, McGonagle D, Bragazzi NL, Tiosano S, Comaneshter D, Shoenfeld Y, Cohen AD, Amital H (2019) Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival. Oncoimmunology 8:e1588084 (epub ahead of print)","journal-title":"Oncoimmunology"},{"key":"4371_CR78","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/1756-185X.13311","volume":"21","author":"G Sargin","year":"2018","unstructured":"Sargin G, Senturk T, Cildag S (2018) Systemic sclerosis and malignancy. Int J Rheum Dis 21:1093\u20131097","journal-title":"Int J Rheum Dis"},{"key":"4371_CR79","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00296-001-0141-3","volume":"21","author":"Y Yang","year":"2001","unstructured":"Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T (2001) Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int 21:106\u2013111","journal-title":"Rheumatol Int"},{"key":"4371_CR80","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/ard.62.8.728","volume":"62","author":"CL Hill","year":"2003","unstructured":"Hill CL, Nguyen AM, Roder D, Roberts-Thomson P (2003) Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 62:728\u2013731","journal-title":"Ann Rheum Dis"},{"key":"4371_CR81","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/ard.2006.056424","volume":"66","author":"EK Pontifex","year":"2007","unstructured":"Pontifex EK, Hill CL, Roberts-Thomson P (2007) Risk factors for lung cancer in patients with scleroderma: a nested case-control study. Ann Rheum Dis 66:551\u2013553","journal-title":"Ann Rheum Dis"},{"key":"4371_CR82","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/art.21225","volume":"52","author":"S Chatterjee","year":"2005","unstructured":"Chatterjee S, Dombi GW, Severson RK, Mayes MD (2005) Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 52:2415\u20132424","journal-title":"Arthritis Rheum"},{"key":"4371_CR83","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10067-004-0940-5","volume":"23","author":"D Launay","year":"2004","unstructured":"Launay D, Le Berre R, Hatron PY, Peyrat JP, Hachulla E, Devulder B, Hebbar M (2004) Association between systemic sclerosis and breast cancer: eight new cases and review of the literature. Clin Rheumatol 23:516\u2013522","journal-title":"Clin Rheumatol"},{"key":"4371_CR84","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00296-008-0540-9","volume":"28","author":"TY Lu","year":"2008","unstructured":"Lu TY, Hill CL, Pontifex EK, Roberts-Thomson PJ (2008) Breast cancer and systemic sclerosis: a clinical description of 21 patients in a population-based cohort study. Rheumatol Int 28:895\u2013899","journal-title":"Rheumatol Int"},{"key":"4371_CR85","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/ard.52.7.531","volume":"52","author":"AK Rosenthal","year":"1993","unstructured":"Rosenthal AK, McLaughlin JK, Linet MS, Persson I (1993) Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 52:531\u2013533","journal-title":"Ann Rheum Dis"},{"key":"4371_CR86","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/art.1780281204","volume":"28","author":"AD Roumm","year":"1985","unstructured":"Roumm AD, Medsger TA Jr (1985) Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 28:1336\u20131340","journal-title":"Arthritis Rheum"},{"key":"4371_CR87","first-page":"300","volume":"86","author":"SF Pan","year":"1975","unstructured":"Pan SF, Rodnan GP, Deutsch M, Wald N (1975) Chromosomal abnormalities in progressive systemic sclerosis (scleroderma) with consideration of radiation effects. J Lab Clin Med 86:300\u2013308","journal-title":"J Lab Clin Med"},{"key":"4371_CR88","first-page":"832","volume":"32","author":"D Khanna","year":"2005","unstructured":"Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Korn JH, Merkel PA, Rothfield N, Wigley FM, Moreland LW, Silver R, Steen VD, Weisman M, Mayes MD, Collier DH, Medsger TA Jr, Seibold JR (2005) Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 32:832\u2013840","journal-title":"J Rheumatol"},{"key":"4371_CR89","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/art.23524","volume":"59","author":"BD Thombs","year":"2008","unstructured":"Thombs BD, Hudson M, Taillefer SS, Baron M (2008) Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum 59:504\u2013509","journal-title":"Arthritis Rheum"},{"key":"4371_CR90","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/art.23343","volume":"59","author":"M Hudson","year":"2008","unstructured":"Hudson M, Steele R, Taillefer S, Baron M (2008) Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II. Arthritis Rheum 59:270\u2013278","journal-title":"Arthritis Rheum"},{"key":"4371_CR91","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1365-2133.2011.10624.x","volume":"166","author":"H Muller","year":"2012","unstructured":"Muller H, Rehberger P, Gunther C, Schmitt J (2012) Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma. Br J Dermatol 166:343\u2013353","journal-title":"Br J Dermatol"},{"key":"4371_CR92","first-page":"2236","volume":"34","author":"A Villaverde-Hueso","year":"2007","unstructured":"Villaverde-Hueso A, Sanchez-Valle E, Alvarez E, Morant C, Carreira PE, Martin-Arribas MC, Genova R, Ramirez-Gonzalez A, de la Paz MP (2007) Estimating the burden of scleroderma disease in Spain. J Rheumatol 34:2236\u20132242","journal-title":"J Rheumatol"},{"key":"4371_CR93","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/art.22910","volume":"57","author":"BD Thombs","year":"2007","unstructured":"Thombs BD, Taillefer SS, Hudson M, Baron M (2007) Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum 57:1089\u20131097","journal-title":"Arthritis Rheum"},{"key":"4371_CR94","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0304-3959(01)00409-2","volume":"95","author":"LM Benrud-Larson","year":"2002","unstructured":"Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, Boling C, Reed J, White B, Wigley FM (2002) The impact of pain and symptoms of depression in scleroderma. Pain 95:267\u2013275","journal-title":"Pain"},{"key":"4371_CR95","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000056240","volume":"70","author":"NV Angelopoulos","year":"2001","unstructured":"Angelopoulos NV, Drosos AA, Moutsopoulos HM (2001) Psychiatric symptoms associated with scleroderma. Psychother Psychosom 70:145\u2013150","journal-title":"Psychother Psychosom"},{"key":"4371_CR96","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/art.1780390623","volume":"39","author":"RP Roca","year":"1996","unstructured":"Roca RP, Wigley FM, White B (1996) Depressive symptoms associated with scleroderma. Arthritis Rheum 39:1035\u20131040","journal-title":"Arthritis Rheum"},{"key":"4371_CR97","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jbspin.2003.11.008","volume":"72","author":"C Legendre","year":"2005","unstructured":"Legendre C, Allanore Y, Ferrand I, Kahan A (2005) Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine 72:408\u2013411","journal-title":"Joint Bone Spine"},{"issue":"Suppl 105","key":"4371_CR98","first-page":"35","volume":"35","author":"S Perrot","year":"2017","unstructured":"Perrot S, Peixoto M, Dieude P, Hachulla E, Avouac J, Ottaviani S, Allanore Y (2017) Patient phenotypes in fibromyalgia comorbid with systemic sclerosis or rheumatoid arthritis: influence of diagnostic and screening tests. Screening with the FiRST questionnaire, diagnosis with the ACR 1990 and revised ACR 2010 criteria. Clin Exp Rheumatol 35(Suppl 105):35\u201342","journal-title":"Clin Exp Rheumatol"},{"key":"4371_CR99","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.reuma.2017.02.008","volume":"14","author":"MS El-Rabbat","year":"2018","unstructured":"El-Rabbat MS, Mahmoud NK, Gheita TA (2018) Clinical significance of fibromyalgia syndrome in different rheumatic diseases: relation to disease activity and quality of life. Reumatol Clin 14:285\u2013289","journal-title":"Reumatol Clin"},{"key":"4371_CR100","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","volume":"50","author":"M Bassel","year":"2011","unstructured":"Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD (2011) Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology (Oxford) 50:762\u2013767","journal-title":"Rheumatology (Oxford)"},{"key":"4371_CR101","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s00296-013-2680-9","volume":"33","author":"MA Sariyildiz","year":"2013","unstructured":"Sariyildiz MA, Batmaz I, Budulgan M, Bozkurt M, Yazmalar L, Inanir A, Celepkolu T, Cevik R (2013) Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life. Rheumatol Int 33:1973\u20131979","journal-title":"Rheumatol Int"},{"key":"4371_CR102","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S1389-9457(02)00013-8","volume":"3","author":"GF Prado","year":"2002","unstructured":"Prado GF, Allen RP, Trevisani VM, Toscano VG, Earley CJ (2002) Sleep disruption in systemic sclerosis (scleroderma) patients: clinical and polysomnographic findings. Sleep Med 3:341\u2013345","journal-title":"Sleep Med"},{"key":"4371_CR103","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/rheumatology\/ker020","volume":"50","author":"T Frech","year":"2011","unstructured":"Frech T, Hays RD, Maranian P, Clements PJ, Furst DE, Khanna D (2011) Prevalence and correlates of sleep disturbance in systemic sclerosis\u2014results from the UCLA scleroderma quality of life study. Rheumatology (Oxford) 50:1280\u20131287","journal-title":"Rheumatology (Oxford)"},{"key":"4371_CR104","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/MCP.0000000000000215","volume":"21","author":"SR Sangle","year":"2015","unstructured":"Sangle SR, Tench CM, D\u2019Cruz DP (2015) Autoimmune rheumatic disease and sleep: a review. Curr Opin Pulm Med 21:553\u2013556","journal-title":"Curr Opin Pulm Med"},{"key":"4371_CR105","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13075-019-1842-x","volume":"21","author":"EH Park","year":"2019","unstructured":"Park EH, Strand V, Oh YJ, Song YW, Lee EB (2019) Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study. Arthritis Res Ther 21:61","journal-title":"Arthritis Res Ther"},{"key":"4371_CR106","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/03009740600704296","volume":"35","author":"RB Souza","year":"2006","unstructured":"Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35:384\u2013387","journal-title":"Scand J Rheumatol"},{"key":"4371_CR107","first-page":"1822","volume":"27","author":"K Neumann","year":"2000","unstructured":"Neumann K, Wallace DJ, Metzger AL (2000) Osteoporosis\u2014less than expected in patients with scleroderma? J Rheumatol 27:1822\u20131823","journal-title":"J Rheumatol"},{"key":"4371_CR108","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s00296-018-4139-5","volume":"38","author":"M Fauny","year":"2018","unstructured":"Fauny M, Bauer E, Albuisson E, Perrier-Cornet J, Deibener J, Chabot F, Mandry D, Huttin O, Chary-Valckenaere I, Loeuille D (2018) Vertebral fracture prevalence and measurement of the scanographic bone attenuation coefficient on CT-scan in patients with systemic sclerosis. Rheumatol Int 38:1901\u20131910","journal-title":"Rheumatol Int"},{"key":"4371_CR109","first-page":"313","volume":"22","author":"B Frediani","year":"2004","unstructured":"Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A, Siagri C, Chellini F, Capperucci C, Filipponi P, Galeazzi M, Marcolongo R (2004) Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis. Clin Exp Rheumatol 22:313\u2013318","journal-title":"Clin Exp Rheumatol"},{"key":"4371_CR110","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00223-016-0119-5","volume":"99","author":"C Caimmi","year":"2016","unstructured":"Caimmi C, Caramaschi P, Barausse G, Orsolini G, Idolazzi L, Gatti D, Viapiana O, Adami S, Biasi D, Rossini M (2016) Bone metabolism in a large cohort of patients with systemic sclerosis. Calcif Tissue Int 99:23\u201329","journal-title":"Calcif Tissue Int"},{"key":"4371_CR111","first-page":"S-28-32","volume":"32","author":"MA Omair","year":"2014","unstructured":"Omair MA, McDonald-Blumer H, Johnson SR (2014) Bone disease in systemic sclerosis: outcomes and associations. Clin Exp Rheumatol 32:S-28-32","journal-title":"Clin Exp Rheumatol"},{"key":"4371_CR112","doi-asserted-by":"publisher","first-page":"e66991","DOI":"10.1371\/journal.pone.0066991","volume":"8","author":"M Atteritano","year":"2013","unstructured":"Atteritano M, Sorbara S, Bagnato G, Miceli G, Sangari D, Morgante S, Visalli E, Bagnato G (2013) Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS One 8:e66991","journal-title":"PLoS One"},{"key":"4371_CR113","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1136\/annrheumdis-2013-204832","volume":"74","author":"CC Lai","year":"2015","unstructured":"Lai CC, Wang SH, Chen WS, Liu CJ, Chen TJ, Lee PC, Chang YS (2015) Increased risk of osteoporotic fractures in patients with systemic sclerosis: a nationwide population-based study. Ann Rheum Dis 74:1347\u20131352","journal-title":"Ann Rheum Dis"},{"key":"4371_CR114","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/1756-185X.12242","volume":"19","author":"G Kilic","year":"2016","unstructured":"Kilic G, Kilic E, Akgul O, Ozgocmen S (2016) Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Int J Rheum Dis 19:405\u2013411","journal-title":"Int J Rheum Dis"},{"key":"4371_CR115","doi-asserted-by":"publisher","first-page":"224","DOI":"10.31138\/mjr.29.4.224","volume":"29","author":"C Skarlis","year":"2018","unstructured":"Skarlis C, Palli E, Nezos A, Koutsilieris M, Mavragani CP (2018) Study of the incidence of osteoporosis in patients with Sj\u00f6gren\u2019s syndrome (pSS) and investigation of activation of the RANKL\/RANK and osteoprotegerin (OPG) system. Mediterr J Rheumatol 29:224\u2013227","journal-title":"Mediterr J Rheumatol"},{"key":"4371_CR116","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00296-010-1421-6","volume":"31","author":"SK Shinjo","year":"2011","unstructured":"Shinjo SK, Bonfa E, de Falco Caparbo V, Pereira RM (2011) Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency. Rheumatol Int 31:1075\u20131080","journal-title":"Rheumatol Int"},{"key":"4371_CR117","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1183\/09031936.00226711","volume":"41","author":"G Parati","year":"2013","unstructured":"Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, Levy P, Riha R, Bassetti C, Narkiewicz K, Mancia G, McNicholas WT, Members ECAB (2013) Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 41:523\u2013538","journal-title":"Eur Respir J"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04371-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04371-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04371-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T23:13:41Z","timestamp":1594422821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04371-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":117,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["4371"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04371-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"25 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors disclose that they do not have any financial or other relationships, which might lead to a conflict of interest regarding this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}